Biocon Limited has informed the Exchange regarding a press release dated Jun 27, 2025, titled "Biocon Biologics Receives Health Canada Approval for Yesafili (aflibercept); First Global Launch Scheduled for July 2025".
Biocon Limited has informed the Exchange regarding a press release dated Jun 27, 2025, titled "Biocon Biologics Receives Health Canada Approval for Yesafili (aflibercept); First Global Launch Scheduled for July 2025".